U.S. Cannabis Industry Returns to Growth as Rescheduling Looms

Dow Jones
08/22

1511 ET - U.S. cannabis operators largely showed a return to year-over-year growth in 2Q, which is well-timed as the industry waits for a wider reclassification of cannabis to a less dangerous drug schedule, Alliance Global Partners analyst Aaron Grey says in a research note. Six of the leading 8 operators reported growth, making it the first time in two years that there has been growth on average for the industry, the analyst says. It's also a meaningful turnaround compared with 2025, Grey says. Growth should continue as store saturation becomes less of a factor for retail trends and wholesale trends remain stable, the analyst says. Meanwhile, the federal government's rescheduling of cannabis could come later this fall, Grey says. The growth and reform would combine to make cannabis companies look more appealing to investors, the analyst says.

 

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10